Novartis Ag (NVS) EBIT (2009 - 2026)
Novartis Ag (NVS) posted EBIT of $4.75 billion for Q2 2026, down 2.3% from $4.86 billion a year earlier but up 12.2% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) EBIT (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT at Novartis Ag was $17.1 billion, up 2.5% year-over-year; for FY2025, it was $17.64 billion, up 21.3% from FY2024.
- Annual EBIT has increased for three consecutive years, with a five-year compound annual growth rate of 11.7% (FY2020 to FY2025).
- In prior years, Novartis Ag's EBIT was $14.54 billion in FY2024 (+48.9%), $9.77 billion in FY2023 (+22.9%), $7.95 billion in FY2022 (-21.0%) and $10.06 billion in FY2021 (-0.9%).
- Quarterly EBIT has run from a low of $1.76 billion in Q4 2022 to a high of $4.86 billion in Q2 2025 over five years.
- On a year-over-year basis, EBIT increased in six of the last eight quarters, with growth averaging 27.1%.
- The strongest year-over-year quarter for EBIT in the past five years was Q3 2024, with growth of 105.8%; the weakest was Q3 2022, with a decline of 43.5%.
- According to Business Quant data, EBIT for the three prior quarters was $4.24 billion (Q1 2026), $3.62 billion (Q4 2025) and $4.5 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Vertex Pharmaceuticals | 133.33 Bn | 105.34 Bn | 2.84 Bn | 1.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.75 Bn |
| Mar 31, 2026 | 4.24 Bn |
| Dec 31, 2025 | 3.62 Bn |
| Sep 30, 2025 | 4.50 Bn |
| Jun 30, 2025 | 4.86 Bn |
| Mar 31, 2025 | 4.66 Bn |
| Dec 31, 2024 | 3.53 Bn |
| Sep 30, 2024 | 3.63 Bn |
| Jun 30, 2024 | 4.01 Bn |
| Mar 31, 2024 | 3.37 Bn |
| Dec 31, 2023 | 2.58 Bn |
| Sep 30, 2023 | 1.76 Bn |
| Jun 30, 2023 | 2.81 Bn |
| Mar 31, 2023 | 2.62 Bn |
| Dec 31, 2022 | 1.76 Bn |
| Sep 30, 2022 | 1.83 Bn |
| Jun 30, 2022 | 2.23 Bn |
| Mar 31, 2022 | 2.85 Bn |
| Dec 31, 2021 | 2.56 Bn |
| Sep 30, 2021 | 3.23 Bn |
API Access
Novartis Ag EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();